Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-164414
Filing Date
2025-07-24
Accepted
2025-07-24 16:12:13
Documents
3
Period of Report
2025-07-24

Document Format Files

Seq Description Document Type Size
1 6-K d945399d6k.htm 6-K 15186
2 EX-1.1 d945399dex11.htm EX-1.1 269402
3 EX-5.1 d945399dex51.htm EX-5.1 23929
  Complete submission text file 0001193125-25-164414.txt   309572
Mailing Address 7 BD HAUSSMANN PARIS France
Business Address 7 BD HAUSSMANN PARIS France 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41842 | Film No.: 251147016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)